Nucleophosmin mutations in acute myeloid leukemia: A tale of protein unfolding and mislocalization

Protein Science

Volumn 22, Issue 5, 2013, Pages 545-556

  Federici, Luca ^a   Falini, Brunangelo ^b  

^a UNIVERSITY OF CHIETI   (Italy)

^b UNIVERSITY OF PERUGIA   (Italy)

Author keywords

Acute myeloid leukemia; B23; G quadruplex DNA; NPM1; Nucleolus; Unfolding

Indexed keywords

GUANINE QUADRUPLEX; NUCLEIC ACID BINDING PROTEIN; NUCLEOPHOSMIN;

ACUTE GRANULOCYTIC LEUKEMIA; BIOGENESIS; CARBOXY TERMINAL SEQUENCE; CELL FUNCTION; CELL NUCLEUS; CENTROSOME; CHROMATIN ASSEMBLY AND DISASSEMBLY; CHROMOSOME TRANSLOCATION; DNA REPAIR; GENE MUTATION; HEMATOLOGIC DISEASE; HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN POLYMORPHISM; PROTEIN PROCESSING; PROTEIN STABILITY; PROTEIN UNFOLDING; REVIEW; RIBOSOME; SOLID TUMOR;

ACTIVE TRANSPORT, CELL NUCLEUS; AMINO ACID SEQUENCE; ANIMALS; G-QUADRUPLEXES; GENE EXPRESSION REGULATION, LEUKEMIC; HUMANS; LEUKEMIA, MYELOID, ACUTE; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUTATION; NUCLEAR PROTEINS; PROTEIN FOLDING;

EID: 84878167460     PISSN: 09618368     EISSN: 1469896X     Source Type: Journal    
DOI: 10.1002/pro.2240     Document Type: Review

References (84)

1. Kang YJ, Olson MO, Jones C, Busch H (1975) Nucleolar phosphoproteins of normal rat liver and Novikoff hepatoma ascites cells. Cancer Res 35:1470-1475.
2. Schmidt-Zachmann MS, Hugle-Dorr B, Franke WW (1987) A constitutive nucleolar protein identified as a member of the nucleoplasmin family. EMBO J 6: 1881-1890.
3. Borer RA, Lehner CF, Eppenberger HM, Nigg EA (1989) Major nucleolar proteins shuttle between nucleus and cytoplasm. Cell 56:379-390.
4. Murano K, Okuwaki M, Hisaoka M, Nagata K (2008) Transcription regulation of the rRNA gene by a multifunctional nucleolar protein, B23/nucleophosmin, through its histone chaperone activity. Mol Cell Biol 28:3114-3126. (Pubitemid 351657078)
5. Savkur RS, Olson MO (1998) Preferential cleavage in pre-ribosomal RNA by protein B23 endoribonuclease. Nucleic Acids Res 26:4508-4515. (Pubitemid 28442146)
6. Maggi LB, Jr, Kuchenruether M, Dadey DY, Schwope RM, Grisendi S, Townsend RR, Pandolfi PP, Weber JD (2008) Nucleophosmin serves as a rate-limiting nuclear export chaperone for the Mammalian ribosome. Mol Cell Biol 28:7050-7065.
7. Okuwaki M, Iwamatsu A, Tsujimoto M, Nagata K (2001) Identification of nucleophosmin/B23, an acidic nucleolar protein, as a stimulatory factor for in vitro replication of adenovirus DNA complexed with viral basic core proteins. J Mol Biol 311:41-55. (Pubitemid 32735313)
8. Okuwaki M, Matsumoto K, Tsujimoto M, Nagata K (2001) Function of nucleophosmin/B23, a nucleolar acidic protein, as a histone chaperone. FEBS Lett 506: 272-276. (Pubitemid 32964828)
9. Wang W, Budhu A, Forgues M, Wang XW (2005) Temporal and spatial control of nucleophosmin by the Ran-Crm1 complex in centrosome duplication. Nat Cell Biol 7:823-830. (Pubitemid 41079055)
10. Colombo E, Alcalay M, Pelicci PG (2011) Nucleophosmin and its complex network: a possible therapeutic target in hematological diseases. Oncogene 30: 2595-2609.
11. Frehlick LJ, Eirin-Lopez JM, Ausio J (2006) New insights into the nucleophosmin/nucleoplasmin family of nuclear chaperones. Bioessays 29:49-59.
12. Namboodiri VMH, Akey IV, Schmidt-Zachmann MS, Head JF, Akey CW (2004) The structure and function of Xenopus NO38-core, a histone chaperone in the nucleolus. Structure 12:2149-2160. (Pubitemid 39593194)
13. Lee HH, Kim HS, Kang JY, Lee BI, Ha JY, Yoon HJ, Lim SO, Jung G, Suh SW (2007) Crystal structure of human nucleophosmin-core reveals plasticity of the pentamer-pentamer interface. Proteins 69:672-678. (Pubitemid 47623881)
14. Szebeni A, Olson MO (1999) Nucleolar protein B23 has molecular chaperone activities. Protein Sci 8:905-912. (Pubitemid 29165421)
15. Grisendi S, Mecucci C, Falini B, Pandolfi PP (2006) Nucleophosmin and cancer. Nat Rev Cancer 6:493-505. (Pubitemid 43980539)
16. Lindstrom MS (2011) NPM1/B23: a multifunctional chaperone in ribosome biogenesis and chromatin remodeling. Biochem Res Int 2011:195209.
17. Emmott E, Hiscox JA (2009) Nucleolar targeting: the hub of the matter. EMBO Rep 10:231-238.
18. Hingorani K, Szebeni A, Olson MO (2000) Mapping the functional domains of nucleolar protein B23. J Biol Chem 275:24451-24457. (Pubitemid 30626537)
19. Yu Y, Maggi LB, Jr, Brady SN, Apicelli AJ, Dai MS, LuH, Weber JD (2006) Nucleophosmin is essential for ribosomal protein L5 nuclear export. Mol Cell Biol 26:3798-3809. (Pubitemid 43726397)
20. Nishimura Y, Ohkubo T, Furuichi Y, Umekawa H (2002) Tryptophans 286 and 288 in the C-terminal region of protein B23.1 are important for its nucleolar localization. Biosci Biotechnol Biochem 66:2239-2242. (Pubitemid 39251232)
21. Falini B, Nicoletti I, Bolli N, Martelli MP, Liso A, Gorello P, Mandelli F, Mecucci C, Martelli MF (2007) Translocations and mutations involving the nucleophosmin (NPM1) gene in lymphomas and leukemias. Haematologica 92:519-532. (Pubitemid 350144298)
22. Falini B, Mecucci C, Tiacci E, Alcalay M, Rosati R, Pasqualucci L, La Starza R, Diverio D, Colombo E, Santucci A, Bigerna B, Pacini R, Pucciarini A, Liso A, Vignetti M, Fazi P, Meani N, Pettirossi V, Saglio G, Mandelli F, Lo-Coco F, Pelicci PG, Martelli MF; GIMEMA Acute Leukemia Working Party (2005) Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype. N Engl J Med 352:254-266. (Pubitemid 40110814)
23. Falini B, Nicoletti I, Martelli MF, Mecucci C (2007) Acute myeloid leukemia carrying cytoplasmic/mutated nucleophosmin (NPMc+ AML): biologic and clinical features. Blood 109:874-885. (Pubitemid 46220630)
24. Falini B, Martelli MP, Bolli N, Sportoletti P, Liso A, Tiacci E, Haferlach T (2011) Acute myeloid leukemia with mutated nucleophosmin (NPM1): is it a distinct entity? Blood 117:1109-1120.
25. Grummitt CG, Townsley FM, Johnson CM, Warren J, Bycroft M (2008) Structural consequences of nucleophosmin mutations in acute myeloid leukemia. J Biol Chem 283:23326-23332.
26. Falini B, Mecucci C, Saglio G, Lo Coco F, Diverio D, Brown P, Pane F, Mancini M, Martelli MP, Pileri S, Haferlach T, Haferlach C, Schnittger S (2008) NPM1 mutations and cytoplasmic nucleophosmin are mutually exclusive of recurrent genetic abnormalities: a comparative analysis of 2562 patients with acute myeloid leukemia. Haematologica 93:439-442. (Pubitemid 351398646)
27. Bolli N, Nicoletti I, De Marco MF, Bigerna B, Pucciarini A, Mannucci R, Martelli MP, Liso A, Mecucci C, Fabbiano F, Martelli MF, Henderson BR, Falini B (2007) Born to be exported: COOH-terminal nuclear export signals of different strength ensure cytoplasmic accumulation of nucleophosmin leukemic mutants. Cancer Res 67:6230-6237. (Pubitemid 47037504)
28. Albiero E, Madeo D, Bolli N, Giaretta I, Bona ED, Martelli MF, Nicoletti I, Rodeghiero F, Falini B (2007) Identification and functional characterization of a cytoplasmic nucleophosmin leukaemic mutant generated by a novel exon-11 NPM1 mutation. Leukemia 21: 1099-1103. (Pubitemid 46672090)
29. Falini B, Bolli N, Shan J, Martelli MP, Liso A, Pucciarini A, Bigerna B, Pasqualucci L, Mannucci R, Rosati R, Gorello P, Diverio D, Roti G, Tiacci E, Cazzaniga G, Biondi A, Schnittger S, Haferlach T, Hiddemann W, Martelli MF, Gu W, Mecucci C, Nicoletti I (2006) Both carboxy-terminus NES motif and mutated tryptophan (s) are crucial for aberrant nuclear export of nucleophosmin leukemic mutants in NPMc+ AML. Blood 107:4514-4523. (Pubitemid 43801380)
30. Falini B, Martelli MP, Bolli N, Bonasso R, Ghia E, Pallotta MT, Diverio D, Nicoletti I, Pacini R, Tabarrini A, Galletti BV, Mannucci R, Roti G, Rosati R, Specchia G, Liso A, Tiacci E, Alcalay M, Luzi L, Volorio S, Bernard L, Guarini A, Amadori S, Mandelli F, Pane F, Lo-Coco F, Saglio G, Pelicci PG, Martelli MF, Mecucci C (2006) Immunohistochemistry predicts nucleophosmin (NPM) mutations in acute myeloid leukemia. Blood 108:1999-2005. (Pubitemid 44395013)
31. Arber DA, Brunning RD, Le Beau MM, Falini B, Vardiman JW, Porwit A, Thiele J, Bloomfield CD, Acute myeloid leukaemia with recurrent genetic abnormalities. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW, Eds. (2008) WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon, France: International Agency for Research on Cancer (IARC), pp 110-123.
32. Scaloni F, Gianni S, Federici L, Falini B, Brunori M (2009) Folding mechanism of the C-terminal domain of nucleophosmin: residual structure in the denatured state and its pathophysiological significance. FASEB J 23:2360-2365.
33. Scaloni F, Federici L, Brunori M, Gianni S (2010) Deciphering the folding transition state structure and denatured state properties of nucleophosmin C-terminal domain. Proc Natl Acad Sci USA 107:5447-5452.
34. Chiarella S, De Cola A, Scaglione GL, Carletti E, Graziano V, Barcaroli D, Lo Sterzo C, Di Matteo A, DI Ilio C, Falini B, Arcovito A, De Laurenzi V, Federici L (in press) Nucleophosmin mutations alter its nucleolar localization by impairing G-quadruplex binding at ribosomal DNA. Nucleic Acids Res; doi:10.1093/nar/gkt001.
35. Falini B, Bolli N, Liso A, Martelli MP, Mannucci R, Pileri S, Nicoletti I (2009) Altered nucleophosmin transport in acute myeloid leukaemia with mutated NPM1: molecular basis and clinical implications. Leukemia 23:1731-1743.
36. Quentmeier H, Martelli MP, Dirks WG, Bolli N, Liso A, Macleod RA, Nicoletti I, Mannucci R, Pucciarini A, Bigerna B, Martelli MF, Mecucci C, Drexler HG, Falini B (2005) Cell line OCI/AML3 bears exon-12 NPM gene mutation-A and cytoplasmic expression of nucleophosmin. Leukemia 19:1760-1767. (Pubitemid 41486153)
37. Dumbar TS, Gentry GA, Olson MO (1989) Interaction of nucleolar phosphoprotein B23 with nucleic acids. Biochemistry 28:9495-9501. (Pubitemid 20000728)
38. Wang D, Baumann A, Szebeni A, Olson MO (1994) The nucleic acid binding activity of nucleolar protein B23.1 resides in its carboxyl-terminal end. J Biol Chem 269: 30994-30998. (Pubitemid 24377589)
39. Herrera JE, Savkur R, Olson MO (1995) The ribonuclease activity of nucleolar protein B23. Nucleic Acids Res 23:3974-3979.
40. Palaniswamy V, Moraes KC, Wilusz CJ, Wilusz J (2006) Nucleophosmin is selectively deposited on mRNA during polyadenylation. Nat Struct Mol Biol 13: 429-435. (Pubitemid 43881583)
41. Mukudai Y, Kubota S, Kawaki H, Kondo S, Eguchi T, Sumiyoshi K, Ohgawara T, Shimo T, Takigawa M (2008) Posttranscriptional regulation of chicken ccn2 gene expression by nucleophosmin/B23 during chondrocyte differentiation. Mol Cell Biol 28:6134-6147.
42. Gurumurthy M, Tan CH, Ng R, Zeiger L, Lau J, Lee J, Dey A, Philp R, Li Q, Lim TM, Price DH, Lane DP, Chao SH (2008). Nucleophosmin interacts with HEXIM1 and regulates RNA polymerase II transcription. J Mol Biol 378:302-317.
43. Dhar SK, Lynn BC, Daosukho C, St Clair DK (2004) Identification of nucleophosmin as an NF-kappaB coactivator for the induction of the human SOD2 gene. J Biol Chem 279:28209-28219. (Pubitemid 38900097)
44. Xu Y, Fang F, Dhar SK, St Clair WH, Kasarskis EJ, St Clair DK (2007) The role of a single-stranded nucleotide loop in transcriptional regulation of the human sod2 gene. J Biol Chem 282:15981-15994. (Pubitemid 47100336)
45. Federici L, Arcovito A, Scaglione GL, Scaloni F, Lo Sterzo C, Di Matteo A, Falini B, Giardina B, Brunori M (2010) Nucleophosmin C-terminal leukemia-associated domain interacts with G-rich quadruplex forming DNA. J Biol Chem 285:37138-37149.
46. Huppert JL (2008) Four-stranded nucleic acids: structure, function and targeting of G-quadruplexes. Chem Soc Rev 37:1375-1384.
47. Neidle S (2009) The structures of quadruplex nucleic acids and their drug complexes. Curr Opin Struct Biol 19:239-250.
48. Huppert JL, Balasubramanian S (2005) Prevalence of quadruplexes at the human genome. Nucleic Acid Res 33:2908-2916.
49. Bugaut A, Balasubramanian S (2012) 5'-UTR RNA Gquadruplexes: translation regulation and targeting. Nucleic Acids Res 40:4727-4741.
50. Sissi C, Gatto B, Palumbo M (2011) The evolving world of protein-G-quadruplex recognition: a medicinal chemist's perspective. Biochimie 93:1219-1230.
51. Gonzalez V, Hurley LH (2010) The cMYC NHEIII (1): function and regulation. Annu Rev Pharmacol Toxicol 50:111-129.
52. Brown RV, Danford FL, Gokhale V, Hurley LH, Brooks TA (2011) Demonstration that drug-targeted downregulation of MYC in non-Hodgkins lymphoma is directly mediated through the promoter G-quadruplex. J Biol Chem 286:41018-41027.
53. Gallo A, Lo Sterzo C, Mori M, Di Matteo A, Bertini I, Banci L, Brunori M, Federici L (2012) Structure of nucleophosmin DNA-binding domain and analysis of its complex with a G-quadruplex sequence from the c-MYC promoter. J Biol Chem 287:26539-26548.
54. Tompa P, Fuxreiter M (2008) Fuzzy complexes: polymorphism and structural disorder in protein-protein interactions. Trends Biochem Sci 33:2-8.
55. Guo X, Bulyk ML, Hartemink AJ (2012) Intrinsic disorder within and flanking the DNA-binding domains of human transcription factors. Pac Symp Biocomput 2012:104-115.
56. Marasco D, Ruggiero A, Vascotto C, Poletto M, Scognamiglio PL, Tell G, Vitagliano L (2013) Role of mutual interactions in the chemical and thermal stability of nucleophosmin NPM1 domains. Biochem Biophys Res Commun 430:523-528.
57. Grummt I (1999) Regulation of mammalian ribosomal gene transcription by RNA polymerase I. Prog Nucleic Acid Res Mol Biol 62:109-154.
58. Drygin D, Siddiqui-Jain A, O'Brien S, Schwaebe M, Lin A, Bliesath J, Ho CB, Proffitt C, Trent K, Whitten JP, Lim JK, Von Hoff D, Anderes K, Rice WG (2009) Anticancer activity of CX-3543: a direct inhibitor of rRNA biogenesis. Cancer Res 69:7653-7661.
59. Ramos-Echazábal G, Chinea G, García-Fernández R, Pons T (2012) In silico studies of potential phosphoresidues in the human nucleophosmin/B23: its kinases and related biological processes. J Cell Biochem 113: 2364-2374.
60. Beckmann R, Buchner K, Jungblut PR, Eckerskorn C, Weise C, Hilbert R, Hucho F (1992) Nuclear substrates of protein kinase C. Eur J Biochem 210:45-51.
61. Okuwaki M, Tsujimoto M, Nagata K (2002) The RNA binding activity of a ribosome biogenesis factor, nucleophosmin/ B23, is modulated by phosphorylation with a cell cycle-dependent kinase and by association with its subtype. Mol Biol Cell 13:2016-2030. (Pubitemid 34651489)
62. Amin MA, Matsunaga S, Uchiyama S, Fukui K (2008) Nucleophosmin is required for chromosome congression, proper mitotic spindle formation, and kinetochore-microtubule attachment in HeLa cells. FEBS Lett 582:3839-3844.
63. Yao J, Fu C, Ding X, Guo Z, Zenreski A, Chen Y, Ahmed K, Liao J, Dou Z, Yao X (2004) Nek2A kinase regulates the localization of numatrin to centrosome in mitosis. FEBS Lett 575:112-118. (Pubitemid 39237691)
64. Negi SS, Olson MO (2006) Effects of interphase and mitotic phosphorylation on the mobility and location of nucleolar protein B23. J Cell Sci 119:3676-3685. (Pubitemid 44501871)
65. Shandilya J, Swaminathan V, Gadad SS, Choudhari R, Kodaganur GS, Kundu TK (2009). Acetylated NPM1 localizes in the nucleoplasm and regulates transcriptional activation of genes implicated in oral cancer manifestation. Mol Cell Biol 29:5115-5127.
66. Liu X, Liu Z, Jang SW, Ma Z, Shinmura K, Kang S, Dong S, Chen J, Fukasawa K, Ye K (2007) Sumoylation of nucleophosmin/B23 regulates its subcellular localization, mediating cell proliferation and survival. Proc Natl Acad Sci USA 104:9679-9684. (Pubitemid 47175326)
67. Haindl M, Harasim T, Eick D, Muller S (2008). The nucleolar SUMO-specific protease SENP3 reverses SUMO modification of nucleophosmin and is required for rRNA processing. EMBO Rep 9:273-279. (Pubitemid 351330993)
68. Wulff JE, Siegrist R, Myers AG (2007) The natural product avrainvillamide binds to the oncoprotein nucleophosmin. J Am Chem Soc 129:1444-14451.
69. Gjerset RA (2006) DNA damage, p14arf, nucleophosmin (NPM/B23) and cancer. J Mol Histol 37:239-251. (Pubitemid 44795627)
70. Falini B, Martelli MP, Mecucci C, Liso A, Bolli N, Bigerna B, Pucciarini A, Pileri S, Meloni G, Martelli MF, Haferlach T, Schnittger S (2008) Cytoplasmic mutated nucleophosmin is stable in primary leukemic cells and in a xenotransplant model of NPMc+ acute myeloid leukemia in SCID mice. Haematologica 93: 775-779. (Pubitemid 351669321)
71. Alcalay M, Tiacci E, Bergomas R, Bigerna B, Venturini E, Minardi SP, Meani N, Diverio D, Bernard L, Tizzoni L, Volorio S, Luzi L, Colombo E, Lo Coco F, Mecucci C, Falini B, Pelicci PG (2005) Acute myeloid leukemia bearing cytoplasmic nucleophosmin (NPMc+ AML) shows a distinct gene expression profile characterized by up-regulation of genes involved in stem-cell maintenance. Blood 106:899-902. (Pubitemid 41076430)
72. Garzon R, Garofalo M, Martelli MP, Briesewitz R, Wang L, Fernandez-Cymering C, Volinia S, Liu CG, Schnittger S, Haferlach T, Liso A, Diverio D, Mancini M, Meloni G, Foa R, Martelli MF, Mecucci C, Croce CM, Falini B (2008) Distinctive microRNA signature of acute myeloid leukemia bearing cytoplasmic mutated nucleophosmin. Proc Natl Acad Sci USA 105:3945-3950. (Pubitemid 351723504)
73. Martelli MP, Pettirossi V, Thiede C, Bonifacio E, Mezzasoma F, Cecchini D, Pacini R, Tabarrini A, Ciurnelli R, Gionfriddo I, Manes N, Rossi R, Giunchi L, Oelschlägel U, Brunetti L, Gemei M, Delia M, Specchia G, Liso A, Di Ianni M, Di Raimondo F, Falzetti F, Del Vecchio L, Martelli MF, Falini B (2010) CD34+ cells from AML with mutated NPM1 harbor cytoplasmic mutated nucleophosmin and generate leukemia in immunocompromised mice. Blood 116:3907-3922.
74. Taussig DC, Vargaftig J, Miraki-Moud F, Griessinger E, Sharrock K, Luke T, Lillington D, Oakervee H, Cavenagh J, Agrawal SG, Lister TA, Gribben JG, Bonnet D (2010) Leukemia-initiating cells from some acute myeloid leukemia patients with mutated nucleophosmin reside in the CD34(-) fraction. Blood 115:1976-1984.
75. Falini B, Gionfriddo I, Cecchetti F, Ballanti S, Pettirossi V, Martelli MP (2011) Acute myeloid leukemia with mutated nucleophosmin (NPM1): any hope for a targeted therapy? Blood Rev 25:247-254.
76. Schnittger S, Schoch C, Kern W, Mecucci C, Tschulik C, Martelli MF, Haferlach T, Hiddemann W, Falini B (2005) Nucleophosmin gene mutations are predictors of favorable prognosis in acute myelogenous leukemia with a normal karyotype. Blood 106:3733-3739. (Pubitemid 41739006)
77. Schlenk RF, Döhner K, Krauter J, Fröhling S, Corbacioglu A, Bullinger L, Habdank M, Späth D, Morgan M, Benner A, Schlegelberger B, Heil G, Ganser A, Döhner H; German-Austrian Acute Myeloid Leukemia Study Group (2008) Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia. N Engl J Med 358:1909-1918. (Pubitemid 351620111)
78. Colombo E, Martinelli P, Zamponi R, Shing DC, Bonetti P, Luzi L, Volorio S, Bernard L, Pruneri G, Alcalay M, Pelicci PG (2006) Delocalization and destabilization of the Arf tumor suppressor by the leukemia-associated NPM mutant. Cancer Res 66:3044-3050.
79. Bonetto P, Davoli T, Sironi C, Amati B, Pelicci PG, Colombo E (2008) Nucleophosmin and its AML-associated mutant regulate c-Myc turnover through Fbw7 gamma. J Cell Biol 182:19-26. (Pubitemid 352008617)
80. Leong SM, Tan BX, Bte Ahmad B, Yan T, Chee LY, Ang ST, Tay KG, Koh LP, Yeoh AE, Koay ES, Mok YK, Lim TM (2010) Mutant nucleophosmin deregulates cell death and myeloid differentiation through excessive caspase-6 and -8 inhibition. Blood 116:3286-3296.
81. Noguera NI, Song MS, Divona M, Catalano G, Calvo KL, Garci'a F, Ottone T, Florenzano F, Faraoni I, Battistini L, Colombo E, Amadori S, Pandolfi PP, Lo-Coco F (in press) Nucleophosmin/B26 regulates PTEN through interaction with HAUSP in acute myeloid leukemia. Leukemia; doi:10.1038/leu.2012.314.
82. Boeckler FM, Joerger AC, Jaggi G, Rutherford TJ, Veprintsev DB, Fersht AR (2008) Targeted rescue of a destabilized mutant of p53 by an in silico screened drug. Proc Natl Acad Sci USA 105: 10360-10365.
83. Pey AL, Ying M, Cremades N, Velazquez-Campoy A, Scherer T, Thöny B, Sancho J, Martinez A (2008) Identification of pharmacological chaperones as potential therapeutic agents to treat phenylketonuria. J Clin Invest 118:2858-2867.
84. Joerger AC, Fersht AR (2010) The tumor suppressor p53: from structures to drug discovery. Cold Spring Harb Perspect Biol 2:a000919.